Why so many Alzheimer's drugs fail

Send us Fan MailDr. Mia talks about two composite patients: Barbara and Steve who demonstrate two very different tales of Alzheimer's disease, what's sexy vs not in Alzheimer's research, and disease-modifying therapy that is NOT aducanumab. Dr. Mia's prior NPR Morning Edition interview about aducanumab: https://www.npr.org/sections/health-shots/2021/11/08/1052833252/cost-and-controversy-are-limiting-use-of-new-alzheimers-drugNational Institute of Aging clinical trial search tool: https://www.alzheimers.gov/clinical-trialsSPRINT -Mind original article:https://jamanetwork.com/journals/jama/fullarticle/2723256More SPRINT-mind discussion in a nuanced way. " [get avg SBP in 120s] reduces mild cognitive impairment or reduces the risk for mild cognitive impairment and there seems to be a signal that it reduces dementia, but it’s hard to tell because the trial was cut off early.": https://geripal.org/does-intensive-blood-pressure-lowering/*Dr. Mia Yang does not speak on behalf of her current employer: Atrium Health Wake Forest Baptist or Wake Forest School of Medicine. Views expressed are her own. Transcript and more info on www.miayangmd.comSupport the showVideo on Ask Dr. Mia YouTube channelTranscripts on www.miayangmd.com. Transcripts are automatically generated and may contain minor inaccuracies. Email: [email protected] expressed are exclusive of Dr. Mia Yang and not reflective of her or guest speaker's employers or funders.